[go: up one dir, main page]

WO2011121907A1 - Système de surveillance de la glycémie et méthode afférente - Google Patents

Système de surveillance de la glycémie et méthode afférente Download PDF

Info

Publication number
WO2011121907A1
WO2011121907A1 PCT/JP2011/001469 JP2011001469W WO2011121907A1 WO 2011121907 A1 WO2011121907 A1 WO 2011121907A1 JP 2011001469 W JP2011001469 W JP 2011001469W WO 2011121907 A1 WO2011121907 A1 WO 2011121907A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood glucose
information
glucose measurement
storage unit
unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2011/001469
Other languages
English (en)
Japanese (ja)
Inventor
孝文 野村
康能 永松
俊弘 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Publication of WO2011121907A1 publication Critical patent/WO2011121907A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement

Definitions

  • the present invention relates to a blood glucose measuring device and a blood glucose measuring method for measuring a blood glucose level, for example.
  • the present invention does not merely notify the arrival of the blood sugar level measurement time, but can selectively and automatically generate an alarm only when a specific event occurs when blood sugar measurement is necessary. It is an object of the present invention to provide a measuring device and a blood glucose measuring method.
  • the above-mentioned problem is a blood glucose measurement scheduled time for storing time measuring unit that generates time information, a blood glucose measurement unit that performs blood glucose measurement, and blood glucose measurement scheduled time information that the blood glucose measurement unit performs blood glucose measurement
  • An information storage unit a blood glucose information storage unit for storing blood glucose information obtained by blood glucose measurement by the blood glucose measurement unit; and an alarm means for informing an operator of an alarm for blood glucose measurement.
  • the alarm means informs only when the current time acquired from the section has already reached the scheduled blood glucose measurement time and there is special execution request information that particularly requires the blood glucose measurement section to perform blood glucose measurement. This is achieved by a blood glucose measurement device that is configured to execute an operation.
  • the warning means is configured to execute a notification operation. For this reason, the alarm means does not simply notify the alarm at the scheduled blood glucose measurement time, but notifies only after the occurrence of another special request for measuring the blood glucose level. Further, the notification by the warning means is automatically executed. Therefore, unlike the prior art, an alarm is not notified at every blood glucose measurement scheduled time, so that the user feels noisy by the alarm means and does not turn off the operation. In addition, since the alarm means notifies the alarm by selecting the truly necessary case, it is possible to prompt the user to reliably perform the necessary blood glucose measurement in that case.
  • the prescription change information storage unit that stores prescription change information that is change information of drug prescription information, and the special execution request information is presence information of the prescription change information within a predetermined period,
  • This is a blood glucose measuring device.
  • the special execution request information is information on the presence of prescription change information within a predetermined period, when there is a prescription change, it is determined that it is necessary to perform blood glucose measurement, and The effect etc. can be confirmed reliably.
  • a management target blood glucose level information storage unit that stores management target blood glucose level information that is management target range information of the blood glucose information is included, and the special implementation request information is the management target blood glucose level information within a predetermined period.
  • This is a blood glucose measuring device characterized in that it is information on the presence of blood glucose information that is outside the above range.
  • the special execution request information is information on the presence of blood glucose information outside the management target range within a predetermined period
  • blood glucose measurement is performed in a state where there is a risk of causing serious hypoglycemia or hyperglycemia. It can be surely implemented. For this reason, it becomes possible to change the prescription rapidly thereafter and prevent the occurrence of hypoglycemia or hyperglycemia.
  • the special execution request information is that the blood glucose information corresponding to the blood glucose measurement scheduled time information is an event that does not exist in the blood glucose information storage unit at a predetermined frequency. It is.
  • the special implementation request information increases the frequency of forgetting to measure blood glucose. This can be communicated to the user and forgetting to measure can be avoided.
  • a step information storage unit that stores step information acquired from a step measurement unit that measures the number of steps of the user, and a target blood glucose level information storage unit that stores target blood glucose level information that is target blood glucose level information of the user
  • a target blood glucose level and recommended step count table information storage unit for storing the target blood glucose level information and a target blood glucose level and recommended step count table information which are recommended step count information corresponding to the target blood glucose level information, and the special execution request information includes the step count
  • the step count information in the information storage unit is presence information indicating that the step count information is inferior to the target blood glucose level recommended step count information.
  • the special execution request information is that the step number information in the step number information storage unit is inferior to the target blood glucose level recommended step number information. Therefore, it is possible to notify the user that the exercise is insufficient and to promptly measure the blood glucose level.
  • the above-described problem is that the current time acquired from the time measuring unit that generates time information has already reached the blood glucose measurement scheduled time of the blood glucose measurement main body unit that performs blood glucose measurement.
  • the alarm means for notifying the operator of an alarm for prompting blood glucose measurement is configured to execute a notification operation only when there is special execution request information that particularly requires the execution of blood glucose measurement. This is achieved by the blood glucose measurement method.
  • the alarm is selectively automatically generated only when the blood glucose measurement is required, not simply informing the arrival of the blood glucose measurement time. It is possible to provide a blood glucose measurement device and a blood glucose measurement method capable of performing the above.
  • FIG. 1 is a schematic diagram showing a blood sugar level management system 1 having a blood sugar meter 10 which is a blood sugar measuring device according to an embodiment of the present invention.
  • the blood sugar level management system 1 has a blood glucose meter 10 that measures blood sugar levels of patients and the like.
  • the blood glucose meter 10 is used in self blood glucose measurement (SMBG) in which a patient or the like measures blood glucose level at home or the like based on his / her own judgment.
  • SMBG self blood glucose measurement
  • it has the chip
  • the blood glucose meter 10 also has an event button 13 and a time setting button 14 for inputting to the blood glucose meter 10 that such event information has been implemented when a patient or the like eats or administers insulin. Have.
  • This event information is information that affects the blood glucose level, which is blood glucose information, and is specifically information such as “meal”, “snack”, “spree”, and “insulin” administration. That is, when a patient eats, the usual “breakfast”, “lunch”, “dinner” and “snack” or “spree” have greatly different caloric intakes, and the influence on “blood glucose level” is also greatly different. In many cases, administration of “insulin” before meals naturally has a great influence on “blood glucose level”.
  • the administration of these “meal”, “snack”, “spree”, and “insulin” is an event that affects the blood glucose level, and the patient or the like selectively inputs any event information.
  • the blood glucose level (“100”) is displayed on the left side of the display 12 of the blood glucose meter 10, “date (“ March 27 ””) is displayed on the upper right, and “time ( “18:11”), the event is displayed in the lower part.
  • FIG. 2 is a schematic diagram showing a display example of events.
  • the event display changes in the order of “meal” ⁇ “snack” ⁇ “spree” ⁇ “insulin”.
  • the change of the event display is executed by pressing the event button 13 in FIG. 1, and is determined by long pressing.
  • These event display data such as “meals” are stored in the blood glucose meter 10 in advance.
  • the blood glucose meter 10 has a built-in communication device 15 for communicating with the outside, and the blood glucose level data and the event data stored therein are stored in the blood glucose level management device 3 in FIG. It is configured to be able to transmit. Further, the blood glucose meter 10 is configured to be able to acquire step count information from the pedometer 2 that is the step count measuring unit of FIG.
  • the blood sugar level management system 1 has a blood sugar level management device 3 that acquires blood sugar level information and the like from the blood glucose meter 10 and manages the blood sugar level and the like.
  • the blood glucose meter 10 receives from the blood glucose level management device 3 measurement schedule information such as the blood glucose level measurement date and time described later, and information when there is a change in drug prescription by the attending physician of the user of the blood glucose meter 10.
  • Prescription change date and time information, and management target blood glucose level information that is a target blood glucose level range (for example, 81 mg / dL to 130 mg / dL) set by the medical staff such as the attending physician for the user. It is configured to acquire.
  • the pedometer 2 of FIG. 1 has a configuration capable of acquiring step count information of a user who uses the blood glucose meter 10 and transmits such information to the blood glucose meter 10, for example.
  • the blood glucose meter 10 and the blood glucose level management device 3 in FIG. 1 have a computer and control information.
  • This computer has a CPU, a RAM, a ROM, and the like, and these are arranged, for example, via a bus.
  • This bus has a function of connecting all devices, and is an internal path having an address and a data path.
  • the CPU controls a ROM and the like connected to the bus.
  • the ROM stores various programs and various information.
  • the RAM has a function as an area for comparing the contents of the memory during the program processing or for executing the program.
  • FIG. 3 is a schematic block diagram showing the main configuration of the blood glucose meter 10 of FIG.
  • the blood glucose meter 10 includes a control unit 16, and includes the communication device 15, the event button 13, the time setting button 14, the display 12, and the time measuring unit such as the time measuring device 17, and actually A blood glucose measurement unit 18 or the like that measures the blood glucose level is connected to the control unit 16.
  • the blood glucose meter 10 has, for example, a sounding device 19 as an alarm means as shown in FIG. 3, and when the sounding device 19 operates, the blood glucose meter 10 itself vibrates and an alarm sound is output. It is the composition which becomes.
  • the sounding device 19 may be one that generates only vibration, one that generates only an alarm sound, or one that can switch both.
  • the blood glucose meter 10 has various data storage units 20 as shown in FIG. 3, and FIG. 4 is a schematic block diagram showing the contents of the various data storage units 20.
  • FIG. 3 is a schematic block diagram showing the contents of the various data storage units 20.
  • the contents of each program shown in FIG. 3 and each storage unit shown in FIG. 4 will be described later. Further, in the data arrangement examples in FIGS. 3 and 4, each program and each storage unit are described separately. However, these are described separately for convenience of explanation, and the actual arrangement is described. It is not necessary to be.
  • FIG. 5 is a schematic flowchart showing main operations of the blood sugar level management system 1 according to the present embodiment.
  • the operation of the blood sugar level management system 1 will be described with reference to the flowchart of FIG. 5, and the configuration of FIGS.
  • the blood glucose meter 10 of FIG. 1 uses the blood glucose level data, which is blood glucose information measured by the blood glucose measurement unit 18, as the blood glucose information storage unit 30 of FIG. Remember me. Further, the blood glucose meter 10 receives the measurement schedule data which is the blood glucose measurement scheduled time information of the user of the blood glucose meter 10 from the blood glucose level management device 3 of FIG. 1, and stores it in the measurement schedule data storage unit 31 of FIG. Remember.
  • the measurement schedule data is information such as a scheduled time when the user measures the blood glucose level with the blood glucose meter 10.
  • the blood glucose meter 10 receives the drug prescription change information, that is, prescription change information indicating whether or not the drug prescription has been changed by the attending physician of the user of the blood glucose meter 10 from the blood glucose level management device 3 of FIG.
  • the change date data is received and stored in the prescription change date data storage unit 32 of FIG.
  • the blood glucose meter 10 receives management target blood glucose level data that is target blood glucose level information set by the attending physician for the user of the blood glucose meter 10 from the blood glucose level management device 3 of FIG. It is stored in the target value data storage unit 33.
  • the management target blood sugar level data is, for example, 81 mg / dL to 130 mg / dL, which is a range in which the blood sugar level should be controlled.
  • the blood glucose meter 10 receives the step number information of the user of the blood glucose meter 10 from the pedometer 2 of FIG. 1, and is stored in the step number data storage unit 34 which is the step number information storage unit of FIG.
  • the process proceeds to ST2 in FIG.
  • the blood glucose meter 10 enters a sleep state, and the sleep state is canceled once a second with reference to the time measuring device 17 in FIG.
  • the process proceeds to ST3.
  • the process proceeds to ST4.
  • the measurement time determination unit (program) 21 in FIG. 3 operates, and the current time is set to the scheduled measurement time of the blood glucose level with reference to the measurement schedule data storage unit 31 in FIG. 4 and the timing device 17 in FIG. Determine if it has been reached.
  • the process proceeds to ST5 and thereafter. If the scheduled measurement time has been reached in ST4, the blood glucose meter 10 must measure blood glucose according to the measurement schedule data stored in the measurement schedule data storage unit 31 of FIG. Therefore, conventionally, an alarm is activated at this stage, and the user of the blood glucose meter 10 is notified by voice or the like. However, this frequently causes alarms to be activated, which has led to a situation in which the user dislikes the alarm operation and turns off the alarm. Therefore, in the present embodiment, even if the measurement scheduled time is reached in ST4, the ringing device 19 of FIG.
  • the blood glucose level measurement by the blood glucose measurement unit 18 of the blood glucose meter 10 is particularly necessary ( It is configured to wait (select) the occurrence of a special execution request state) and automatically operate the ringing device 19 for the first time in this case.
  • the prescription change date / time reference period judgment unit (program) 22 of FIG. 3 operates, refers to the prescription change date / time data storage unit 32 of FIG. 4 and acquires the current time data from the timing device 17 of FIG. From the prescription change date and time, for example, it is determined whether it is within one week.
  • the ringing device 19 is operated (ST10), and the user of the blood glucose meter 10 is informed of the necessity of measuring the blood glucose level. It is configured to inform. In other words, if there is a change in prescription by the attending physician within the past week, it is necessary to check the effect of the new prescription, etc., so that blood glucose level measurement by the blood glucose meter main body 18 is particularly necessary (special implementation request state And the sounding device 19 is operated.
  • the existence of the prescription change date data within one week is an example when the special execution request information exists.
  • the blood sugar data search unit (program) 23 of FIG. 3 operates, and the management target blood sugar level data that is the management target blood sugar level data of the measured blood sugar level data storage unit 30 of FIG.
  • the current time data is acquired from the time measuring device 17 of FIG. 3, and the data is outside the range of the management target value within 3 days, for example. For example, it is determined whether or not low blood glucose level data (for example, 80 mg / dL or less) exists.
  • the sounding device 19 is operated (ST10), and the user of the blood glucose meter 10 is informed of the necessity of blood glucose level measurement. That is, in a hypoglycemic state that may cause a serious state, it is determined that it is necessary to reliably perform blood glucose measurement, and the sounding device 19 is operated.
  • the presence of low blood glucose level data within 3 days is an example when special execution request information exists.
  • the number of days is not limited to 3 days, and can be implemented not only for hypoglycemia but also for hyperglycemia.
  • the unmeasured determination unit (program) 24 in FIG. 3 operates, and the blood glucose meter 10 is continuously read, for example, three times with reference to the measurement schedule data storage unit 31 and the measurement blood glucose level data storage unit 30 in FIG. Determine if no measurements have been made.
  • the ringing device 19 When it is determined in ST7 that the measurement has not been performed three times in succession, the ringing device 19 is operated (ST10), and the user of the blood glucose meter 10 is notified of the necessity of blood glucose level measurement. It has become. That is, when a blood glucose measurement is forgotten at a predetermined frequency, an alarm is notified by the blood glucose meter 10, and the user's forgetting to measure the blood glucose level can be prevented.
  • the state where the blood glucose level has not been measured three times in succession is an example when the special execution requirement state is in a state where implementation is necessary.
  • the frequency of forgetting to measure is not limited to 3 consecutive times, and may be set to 2 consecutive times, 4 consecutive times or more, or the number of occurrences of forgotten measurement at a predetermined number of measurements (for example, 3 times out of 5) ).
  • the process proceeds to ST8.
  • the recommended step count data acquisition unit (program) 25 in FIG. 3 operates, and the management target blood glucose level data is acquired with reference to the management target blood glucose level data storage unit 33 in FIG.
  • the recommended step count data corresponding to the management target blood glucose level data is obtained by referring to the recommended step count table storage unit 36 of FIG. 4 which is the target blood glucose level and recommended step count table information, and the recommended step count data of FIG. Store in the storage unit 37.
  • the recommended step achievement determination unit (program) 26 in FIG. 3 operates, and the step count data in the step count data storage unit 34 in FIG. 4 exceeds the recommended step count data in the recommended step count data storage unit 37. Whether or not the number of steps is inferior to the recommended number of steps data.
  • the ringing device 19 is operated (ST10), and the user of the blood glucose meter 10 is informed of the necessity of blood glucose level measurement. It has a configuration. That is, the sounding device 19 is operated to inform the user of the blood glucose meter 10 that exercise is insufficient and to promptly perform blood glucose measurement.
  • the fact that the step count data does not exceed the recommended step count data is an example when the special execution request information exists.
  • an alarm is not notified at every scheduled blood glucose measurement time.
  • the operation of the sounding device 19 is less likely to feel uncomfortable, and the alarm function is not turned off. Further, only when there is an event that affects blood glucose management, the sounding device 19 automatically notifies an alarm, so that the user can recognize that the event exists and reliably perform the necessary blood glucose measurement. be able to.
  • the present invention is not limited to the embodiments described above.
  • Measured blood glucose level data storage unit 31 ... Measurement schedule Data storage unit, 32 ... prescription Additional time data storage unit, 33 ... management target value data storage unit, 34 ... step count data storage unit, 36 ... recommended step count table storage unit, 37 ... the recommended steps data storage unit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Cette invention concerne un dispositif de surveillance de la glycémie, qui non seulement signale l'arrivée à échéance d'un point de surveillance de la glycémie mais peut aussi générer automatiquement une alarme de manière sélective quand la surveillance de la glycémie s'avère particulièrement cruciale ; et une méthode de surveillance de la glycémie. Le dispositif de surveillance de la glycémie (10) selon l'invention comprend une unité de temporisation (17) qui génère des données temporelles, un corps de dispositif de surveillance de la glycémie (18) qui surveille la glycémie, une unité de mémoire pour les points programmés de surveillance de la glycémie (31) auxquels la glycémie est surveillée par une unité de surveillance de la glycémie, une unité de mémoire pour les données glycémiques (30) où sont enregistrées les données glycémiques acquises par l'unité de surveillance de la glycémie, et un moyen d'alarme (19) qui envoie une alarme à un pilote. Ce dispositif de surveillance de la glycémie est conçu de façon que le moyen d'alarme ne résonne que dans le cas où l'heure actuelle acquise par l'unité de temporisation est déjà atteinte et qu'il existe des informations spéciales exigeant l'opération de façon que la glycémie soit tout particulièrement surveillée par l'unité de surveillance de la glycémie.
PCT/JP2011/001469 2010-03-30 2011-03-14 Système de surveillance de la glycémie et méthode afférente Ceased WO2011121907A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010-079892 2010-03-30
JP2010079892A JP5562094B2 (ja) 2010-03-30 2010-03-30 血糖測定装置

Publications (1)

Publication Number Publication Date
WO2011121907A1 true WO2011121907A1 (fr) 2011-10-06

Family

ID=44711677

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2011/001469 Ceased WO2011121907A1 (fr) 2010-03-30 2011-03-14 Système de surveillance de la glycémie et méthode afférente

Country Status (2)

Country Link
JP (1) JP5562094B2 (fr)
WO (1) WO2011121907A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014530157A (ja) * 2011-10-18 2014-11-17 オーチス エレベータ カンパニーＯｔｉｓｅｌｅｖａｔｏｒ Ｃｏｍｐａｎｙ 特別な支援機能を有するエレベータ乗客インターフェイス
JP2017533495A (ja) * 2014-09-10 2017-11-09 アセンシア・ダイアベティス・ケア・ホールディングス・アーゲーＡｓｃｅｎｓｉａ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｈｏｌｄｉｎｇｓ ＡＧ 健康関連の問題の管理のためのスマートロギング

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006009199A1 (fr) * 2004-07-21 2006-01-26 Matsushita Electric Industrial Co., Ltd. Système de gestion du niveau de sucre dans le sang
JP2008515505A (ja) * 2004-10-07 2008-05-15 ノボ・ノルデイスク・エー／エス 疾病の自己管理のための方法とシステム
WO2008136437A1 (fr) * 2007-04-27 2008-11-13 Arkray, Inc. Dispositif de mesure
JP2010142273A (ja) * 2008-12-16 2010-07-01 Omron Healthcare Co Ltd 生体指標管理装置
WO2010095675A1 (fr) * 2009-02-19 2010-08-26 オムロンヘルスケア株式会社 Système pour mesurer des informations biologiques, procédé pour mesurer des informations biologiques, dispositif de mesure de glycémie, dispositif de mesure de composition corporelle et sphygmomanomètre

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006009199A1 (fr) * 2004-07-21 2006-01-26 Matsushita Electric Industrial Co., Ltd. Système de gestion du niveau de sucre dans le sang
JP2008515505A (ja) * 2004-10-07 2008-05-15 ノボ・ノルデイスク・エー／エス 疾病の自己管理のための方法とシステム
WO2008136437A1 (fr) * 2007-04-27 2008-11-13 Arkray, Inc. Dispositif de mesure
JP2010142273A (ja) * 2008-12-16 2010-07-01 Omron Healthcare Co Ltd 生体指標管理装置
WO2010095675A1 (fr) * 2009-02-19 2010-08-26 オムロンヘルスケア株式会社 Système pour mesurer des informations biologiques, procédé pour mesurer des informations biologiques, dispositif de mesure de glycémie, dispositif de mesure de composition corporelle et sphygmomanomètre

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014530157A (ja) * 2011-10-18 2014-11-17 オーチス エレベータ カンパニーＯｔｉｓｅｌｅｖａｔｏｒ Ｃｏｍｐａｎｙ 特別な支援機能を有するエレベータ乗客インターフェイス
US9624071B2 (en) 2011-10-18 2017-04-18 Otis Elevator Company Elevator passenger interface including special assistance features
JP2017533495A (ja) * 2014-09-10 2017-11-09 アセンシア・ダイアベティス・ケア・ホールディングス・アーゲーＡｓｃｅｎｓｉａ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｈｏｌｄｉｎｇｓ ＡＧ 健康関連の問題の管理のためのスマートロギング
JP2020184379A (ja) * 2014-09-10 2020-11-12 アセンシア・ダイアベティス・ケア・ホールディングス・アーゲーＡｓｃｅｎｓｉａ Ｄｉａｂｅｔｅｓ Ｃａｒｅ Ｈｏｌｄｉｎｇｓ ＡＧ 健康関連の問題の管理のためのスマートロギング
JP7127090B2 (ja) 2014-09-10 2022-08-29 アセンシア・ダイアベティス・ケア・ホールディングス・アーゲー 健康関連の問題の管理のためのスマートロギング

Also Published As

Publication number Publication date
JP5562094B2 (ja) 2014-07-30
JP2011206485A (ja) 2011-10-20

Similar Documents

Publication Publication Date Title
JP7670835B2 (ja) グラフィックユーザーインターフェースを備えた薬剤送達システム
AU2021202444A1 (en) Glycemic urgency assessment and alerts interface
CN101198278B (zh) 一种血压测量装置
WO2019230493A1 (fr) Dispositif de gestion d'administration de médicament, procédé de gestion d'administration de médicament, et programme de gestion d'administration de médicament
JP2016535606A (ja) 健康管理を支援するデータ管理ユニット
US20160231308A1 (en) Medical device and method operating same
JP6509232B2 (ja) データ管理ユニットおよびその動作方法
US20190313983A1 (en) User terminal apparatus
US20240387039A1 (en) Patient data collection system and method
US10254153B2 (en) Weight scale and corresponding systems and methods for preventing advancement of congestive heart failure
JP5562094B2 (ja) 血糖測定装置
WO2019230494A1 (fr) Dispositif de gestion d'administration de médicaments, procédé de gestion d'administration de médicaments et programme de gestion d'administration de médicaments
US11116408B2 (en) Biological information measurement support device, biological information measurement device, and biological information measurement support method
US20230317234A1 (en) Computerized system and method for the determination of a drug dosage, and computer program
TW202507494A (zh) 用於計算裝置之螢幕的可客製連續更新的事件監測
US20250134475A1 (en) Analyte monitoring systems
US20240306949A1 (en) Systems and methods for analyte monitoring
US20230042067A1 (en) User-mountable electronic device with deployment guidance features
JP2025533414A (ja) デュアル被検物質センサのためのシステム、装置および方法
HK1221627A1 (zh) 用於手持式糖尿病管理设备的提醒，分类和模式鉴别系统和方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11762160

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11762160

Country of ref document: EP

Kind code of ref document: A1